Ledger.Open graph →
SEC Form D · Amendment · filed January 14, 2021

Immunomic Therapeutics, Inc

Offering
$77.7M
Sold
$77.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ROCKVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Yang-Gon P. Jin · ROCKVILLE, MDDirectorLeise N. Rosman · Phoenix, AZDirectorHyuk Joo P. Jee · ROCKVILLE, MDDirectorJames W. Wishart · ROCKVILLE, MDDirectorArlo P. Mcginn · ROCKVILLE, MDDirectorHyuk Joo P. Jee · ROCKVILLE, MDDirectorNancy Lewis · New York, NYExec · DirectorRonald P. Thiboutot · ROCKVILLE, MDDirectorMichael D. Lack · ROCKVILLE, MDDirectorKris N. Krane · Phoenix, AZExec · DirectorWilliam G. Hearl · ROCKVILLE, MDExec · DirectorAlex S. Kim · ROCKVILLE, MDDirectorHanieh Sadathendi · Los Angeles, CAExec · DirectorJacob Silverman · New York, NYDirectorYang-Gon P. Jin · ROCKVILLE, MDDirectorEric A. Naison-Phillips · New York, NYDirectorEdward W. Forman · New York, NYExec · DirectorKarl N. Chowscano · Phoenix, AZDirectorPatrick Puzzuoli · New York, NYDirectorC. E. Winzer · ROCKVILLE, MDExec · DirectorNoah Gottdiener · New York, NYDirectorArlo P. Mcginn · ROCKVILLE, MDDirectorAlex S. Kim · ROCKVILLE, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗